Cargando…
Mycobacterium leprae’s Infective Capacity Is Associated with Activation of Genes Involved in PGL-I Biosynthesis in a Schwann Cells Infection Model
Peripheral nerves and Schwann cells (SCs) are privileged and protected sites for initial colonization, survival, and spread of leprosy bacillus. Mycobacterium leprae strains that survive multidrug therapy show a metabolic inactivation that subsequently induces the recurrence of typical clinical mani...
Autores principales: | Chavarro-Portillo, Bibiana, Soto, Carlos Y., Guerrero, Martha Inírida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218259/ https://www.ncbi.nlm.nih.gov/pubmed/37240073 http://dx.doi.org/10.3390/ijms24108727 |
Ejemplares similares
-
PGL-III, a Rare
Intermediate of Mycobacterium
leprae Phenolic Glycolipid Biosynthesis, Is a Potent Mincle
Ligand
por: Ishizuka, Shigenari, et al.
Publicado: (2023) -
Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India
por: Pierneef, Louise, et al.
Publicado: (2023) -
Design of a specific peptide against phenolic glycolipid-1 from
Mycobacterium leprae and its implications in leprosy
bacilli entry
por: Arenas, Nelson Enrique, et al.
Publicado: (2022) -
Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms
por: Lima, Mayara Ingrid Sousa, et al.
Publicado: (2020) -
ELISA Test Based on the Phenolic Glycolipid-I (PGL-I) of Mycobacterium leprae: A Reality of a Laboratory from a Non-Endemic Country
por: Longoni, Silvia Stefania, et al.
Publicado: (2022)